ALTIMMUNE
Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs. The company uses a proprietary technology for non-invasive intranasal delivery, and has shown proof of principle in animals and in initial human clinical studies. Vaxin Inc., formerly known as Vaxin Pharmaceuticals and ImmuneFocus Corporation, was founded in 1997 by Emerging Technology Partners. Early experiments revealed that DNA incorporated into an adenovirus can elicit an immune response when placed on the surface of the skin, and subsequently research was expanded to include applications on the skin in the nose as well as experimentation with other vectors.
ALTIMMUNE
Industry:
Biotechnology Clinical Trials Health Care Test And Measurement
Founded:
1997-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.altimmune.com
Total Employee:
11+
Status:
Active
Contact:
8555571369
Total Funding:
51.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Advisor
2019-07-01
Current Employees Featured
M. Scot Roberts Chief Scientific Officer @ Altimmune
Chief Scientific Officer
2012-12-01
Bertrand Georges Chief Technology Officer @ Altimmune
Chief Technology Officer
Richard Eisenstadt Chief Financial Officer @ Altimmune
Chief Financial Officer
2021-12-01
Joe Theis Outside General Counsel @ Altimmune
Outside General Counsel
Vipin Garg President and CEO @ Altimmune
President and CEO
William Brown Chief Financial Officer @ Altimmune
Chief Financial Officer
2019-06-01
Vipin Garg President and Chief Executive Officer @ Altimmune
President and Chief Executive Officer
M Scott Harris Chief Medical Officer @ Altimmune
Chief Medical Officer
2019-09-01
José Ochoa Chief Business Officer @ Altimmune
Chief Business Officer
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-07-09 | Spitfire Pharma | Spitfire Pharma acquired by Altimmune | 93 M USD |
| 2017-01-19 | PharmAthene | PharmAthene acquired by Altimmune | N/A |
| 2015-02-17 | Immune Targeting Systems | Immune Targeting Systems acquired by Altimmune | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Altimmune
HealthCap
HealthCap investment in Post-IPO Equity - Altimmune
Novartis Venture Fund
Novartis Venture Fund investment in Post-IPO Equity - Altimmune
Redmont Capital
Redmont Capital investment in Post-IPO Equity - Altimmune
Truffle Capital
Truffle Capital investment in Post-IPO Equity - Altimmune
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-13 | Altimmune Appoints Richard Eisenstadt as Chief Financial Officer |
Official Site Inspections
http://www.altimmune.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.73 K
- Host name: cloudproxy10064.sucuri.net
- IP address: 192.124.249.64
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Altimmune"
Altimmune - Crunchbase Company Profile & Funding
Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and …See details»
Altimmune, Inc. (ALT) Company Profile & Facts - Yahoo Finance
Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Corporate Governance Altimmune, Inc.’s ISS Governance QualityScore as of January 1, 2025 is 7.See details»
Altimmune, Inc. - LinkedIn
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s …See details»
Board of Directors – Altimmune
Wayne Pisano was elected to join the company’s Board in August of 2018. Mr. Pisano joined the board of directors of Provention Bio, Inc., a biopharmaceutical company, in April of 2018, and …See details»
Greg Weaver, MBA | Altimmune Website
Mr. Weaver joined Altimmune as Chief Financial Officer in November 2024. He has over 25 years of finance experience across a range of publicly-traded and privately-held life sciences …See details»
Altimmune, Inc. (LON: 0A4C) Company Profile & Overview - Stock …
Dec 31, 2024 Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, …See details»
Altimmune Company Profile - Office Locations, Competitors ... - Craft
Oct 28, 2024 Altimmune has 5 employees at their 1 location and $426 k in annual revenue in FY 2023. See insights on Altimmune including office locations, competitors, revenue, financials, …See details»
Altimmune - The Org
Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment …See details»
Board of Directors | Altimmune Website
910 Clopper Road Suite 201-S Gaithersburg, MD 20878 (240) 654-1450See details»
Altimmune - Overview, News & Similar companies | ZoomInfo.com
Who is Altimmune. Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead pr oduct candidate, …See details»
Altimmune - Contacts, Employees, Board Members, Advisors
Organization. Altimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Altimmune has 9 current employee profiles, including Chief Scientific …See details»
SECURITIES AND EXCHANGE COMMISSION - Altimmune
Jan 26, 2024 Altimmune, Inc. ----- (Name of Issuer) Common Stock ... Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) …See details»
Thank you, Altimmune, Inc.! - Obesity Action Coalition
Mar 14, 2024 Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver …See details»
Altimmune Announces Initiation of Phase 2b IMPACT Trial …
GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first …See details»
Raymond Jordt, MBA | Altimmune Website
910 Clopper Road Suite 201-S Gaithersburg, MD 20878 (240) 654-1450See details»
Altimmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that new data showing …See details»
Altimmune Inc, ALT:NMQ profile - FT.com - Financial Times
Dec 31, 2024 Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, …See details»
Altimmune initiated with a Buy at Stifel | Markets Insider
3 days ago Altimmune’s lead asset, pemvidutide/ALT-801, falls squarely in that trend, combining the potent weight-loss effects of GLP-1 with glucagon’s direct liver-targeted lipid metabolism, …See details»
Altimmune CEO on what’s next for its experimental obesity drug
Dec 3, 2024 Vipin Garg, Altimmune CEO, joins 'Fast Money' to discuss Altimmune announcing topline results from its obesity drug trial, potential commercial partnership and more.See details»
Karen Smith, MBA | Altimmune Website
Prior to joining Altimmune, Ms. Smith served as SVP of Finance for ICF, where she managed the Financial Planning and Analysis, Government Compliance and Financial Reporting Systems …See details»